Nevada Medicaid and Nevada Check Up News (Third Quarter 2024 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

Unwinding COVID-19 Information

Known System Issues-Click HERE

Paper claims are no longer accepted by Nevada Medicaid. Please refer to Web Announcement 1733 and Web Announcement 1829 for additional information.

Top 10 Claim Denial Reasons and Resolutions/Workarounds for November 2024 Professional Claims. See Web Announcement 3509.

Top Enrollment Return Reasons and Resolutions for January 2024 Submissions. See Web Announcement 3350.

Top Prior Authorization Denial Reasons for the Third Quarter of 2024. See Web Announcement 3488.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Notice Date Title
Sep 22, 2011 Agenda for September 22 Meeting
Sep 22, 2011 For Review at September 22 Meeting: Anticoagulants (Oral Drugs): Caeriovascular Anticoagulants
Sep 22, 2011 For Review at September 22 Meeting: Anticoagulants (Oral Drugs): Xarelto
Sep 22, 2011 For Review at September 22 Meeting: Cardiovascular: Angiotensin II Receptor Blockers and Diuretic Combinations
Sep 22, 2011 For Review at September 22 Meeting: Cardiovascular: Angiotensin II Receptor Blockers and Diuretic Combinations (Edarbi)
Sep 22, 2011 For Review at September 22 Meeting: Cardiovascular: Direcrt Renin Inhibitors and Combinations
Sep 22, 2011 For Review at September 22 Meeting: Cardiovascular: Direcrt Renin Inhibitors and Combinations (Amturnide)
Sep 22, 2011 For Review at September 22 Meeting: Diabetic Agents: Other Agents (Kombialyze XR)
Sep 22, 2011 For Review at September 22 Meeting: Hepatitis C Agents (Protease Inhibitors)
Sep 22, 2011 For Review at September 22 Meeting: Ophthalmic Antihistamines
Sep 22, 2011 For Review at September 22 Meeting: Ophthalmic Non Steroidal Anti Inflammatory Agents
Sep 22, 2011 For Review at September 22 Meeting: Ophthalmic Quinolones
Sep 22, 2011 For Review at September 22 Meeting: Respiratory: Bronchodilators for COPD
Sep 22, 2011 For Review at September 22 Meeting: Respiratory: Bronchodilators for COPD Arcapta
Sep 22, 2011 For Review at September 22 Meeting: Respiratory: Inhaled Corticosteroid?Beta-Adrenergic Combinations
May 17, 2011 Agenda for June 23 Meeting
May 11, 2011 For Review at June 23 Meeting: Analgesics: Long-Acting Narcotics
May 11, 2011 For Review at June 23 Meeting: Androgenic Agents: Topical Agents (Axiron®)
May 11, 2011 For Review at June 23 Meeting: Androgenic Agents: Topical Agents (Fortesta™)
May 11, 2011 For Review at June 23 Meeting: Antipsychotics: Oral, Atypical
May 11, 2011 For Review at June 23 Meeting: Bone Ossification Agents: Bisphosphonates
May 11, 2011 For Review at June 23 Meeting: Cardiovascular: Angiotensin II Receptor Blockers and Diuretic Combinations
May 11, 2011 For Review at June 23 Meeting: Cardiovascular: Angiotensin II Receptor Blockers and Diuretic Combinations (Edarbi™)
May 11, 2011 For Review at June 23 Meeting: Cardiovascular: Direct Renin Inhibitors and Combinations
May 11, 2011 For Review at June 23 Meeting: Cardiovascular: Direct Renin Inhibitors and Combinations (Amturnide™)
May 11, 2011 For Review at June 23 Meeting: Central Nervous System: ADHD/Stimulants
May 11, 2011 For Review at June 23 Meeting: Diabetic Agents: Other Agents (Kombiglyze™ XR)
May 11, 2011 For Review at June 23 Meeting: Gastrointestinal Agents: Proton Pump Inhibitors
May 11, 2011 For Review at June 23 Meeting: Multiple Sclerosis Agents: Disease Modifying
May 11, 2011 For Review at June 23 Meeting: Ophthalmic Antihistamines
May 11, 2011 For Review at June 23 Meeting: Ophthalmic Non-Steroidal Anti-Inflammatory Agents
May 11, 2011 For Review at June 23 Meeting: Ophthalmic Quinolones
May 11, 2011 For Review at June 23 Meeting: Pancreatic Enzymes
May 11, 2011 For Review at June 23 Meeting: Respiratory: Inhaled Corticosteroid/Beta-Adrenergic Combinations
May 11, 2011 For Review at June 23 Meeting: Respiratory: Short-Acting Beta Adrenergic - Inhalers/Nebs
May 11, 2011 For Review at June 23 Meeting: Skeletal Muscle Relaxants
Feb. 16, 2011 Agenda for March 24 Meeting
Feb. 7, 2011 For Review at March 24 Meeting: Androgenic Agents: Topical (Axiron®)
Feb. 7, 2011 For Review at March 24 Meeting: Androgenic Agents: Topical (Endocrine Androgenic Agents)
Feb. 7, 2011 For Review at March 24 Meeting: Androgenic Agents: Topical (Fortesta™)
Feb. 7, 2011 For Review at March 24 Meeting: Diabetic Agents: Other Agents (Incretin Mementics Enhancers)
Feb. 7, 2011 For Review at March 24 Meeting: Diabetic Agents: Other Agents (Kombiglyze™ XR)
Feb. 7, 2011 For Review at March 24 Meeting: Gastrointestinal Agents: PPIs
Feb. 7, 2011 For Review at March 24 Meeting: Opiate Dependence Treatments
Feb. 7, 2011 For Review at March 24 Meeting: Respiratory: Inhaled Corticosteroid/Beta-Adrenergic Combinations
Feb. 7, 2011 For Review at March 24 Meeting: Skeletal Muscle Relaxants

Return to Past Meeting Reports.